ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 17 Sat January Expiry

Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 17 Sat January Expiry Which Call CE or PUT PE options to buy or sell in Arrowhead Pharmaceuticals, Inc. ARWR

0   ARWR Most Active Call Put Options

ARWR SPOT Price: 63.84 as on 16 Jan, 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) target & price

ARWR Target Price
Target up: 67.79
Target up: 65.82
Target up: 65.29
Target up: 64.75
Target down: 62.78
Target down: 62.25
Target down: 61.71

Date Close Open High Low Volume
16 Fri Jan 202663.8466.4566.7363.691.57 M
15 Thu Jan 202666.2665.7268.2465.720.88 M
14 Wed Jan 202665.9165.2566.0464.721.85 M
13 Tue Jan 202665.5465.8168.4465.471.45 M
12 Mon Jan 202665.9364.5766.6963.332.53 M
09 Fri Jan 202664.5565.0067.0363.451.33 M
08 Thu Jan 202665.0067.3269.4264.556.96 M
07 Wed Jan 202665.6966.1367.3563.007.16 M
Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 17 Sat January Expiry

ARWR Option Chain Data Analysis for Arrowhead Pharmaceuticals, Inc. ARWR option chain

Maximum Call writing has been for strikes:
Until yesterday Maximum Call writing has been for strikes:

Open Interest of Call writers for the options of Arrowhead Pharmaceuticals, Inc. ARWR is shifting downwards. This would mean that markets are slowly moving downwards, and buying CALLS and CE might not be profitable.

Maximum Put writing has been for strikes:
Until yesterday Maximum Put writing has been for strikes:

Open Interest of PUT writers for the options of Arrowhead Pharmaceuticals, Inc. ARWR is shifting downwards. This would mean that markets are slowly moving downwards, and buying PUTS and PE might be more profitable. However, above mentioned levels will serve as support so avoid buying PE below those above mentioned levels.

ARWR Option Chain Price Analysis for Arrowhead Pharmaceuticals, Inc. ARWR option chain

Stock is in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Arrowhead Pharmaceuticals, Inc. ARWR at this time.

It appears as if Arrowhead Pharmaceuticals, Inc. ARWR gave a large move recently.

Stock of Arrowhead Pharmaceuticals, Inc. (ARWR) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, and the stock might move lower...

My analysis of Arrowhead Pharmaceuticals, Inc. is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Arrowhead Pharmaceuticals, Inc. stays below 65, but if it comes above 65, then a intra day buy could be more profitable.
If you take a sell trade below 65, then use 65 as stoploss and 62.4 as target. However if you take a buy trade in Arrowhead Pharmaceuticals, Inc., then use 65 as stoploss and 67.11 as target.

Arrowhead Pharmaceuticals, Inc. ARWR Option Chain, OTM CE, ITM PE

Below is full option chain of Arrowhead Pharmaceuticals, Inc. for strikes which are OTM CALLS (CE), and ITM PUTS (PE).
These are CALLS which have only time value in them, no intrinsic value. PUTS however have both time value and intrinsic value in the premium.

Arrowhead Pharmaceuticals, Inc. ARWR Option Chain, ITM CE, OTM PE

Below is full option chain of Arrowhead Pharmaceuticals, Inc. for strikes which are ITM CALLS (CE), and OTM PUTS (PE).
These are PUTS which have only time value in them, no intrinsic value. CALLS however have both time value and intrinsic value in the premium.

Videos related to: Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 17 Sat January Expiry

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Basics How To Trade In FnO Futures Options Stock Market

Munafa ARWR (target) price & Options chain analysis (Arrowhead Pharmaceuticals, Inc.) Option chain analysis (ARWR) 17 Sat January Expiry

 

Back to top